Antenatal Examinations

katlin65202 Voidal Ash1999 562 Users are discussing this topic

PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

See also: Pregnancy - Screening Tests written for patients

See also separate Antenatal Care, Antenatal Screening for Down's Syndrome and Prenatal Diagnosis articles. This article cannot cover all areas of clinical practice associated with the proper care of pregnant women but gives an overview of important areas, based on the latest guidance. The National Institute for Health and Care Excellence (NICE) provides full advice on the routine care of healthy pregnant women.[1]

  • Diagnosis of pregnancy is best confirmed using a urine-testing kit that determines the presence of beta human chorionic gonadotrophin (beta-hCG).
  • Many women will have confirmed their own pregnancy by such means.
  • Where the absence of menses is the only current indicator of early pregnancy, it is important to confirm pregnancy using a testing kit.
  • An early ultrasound scan should be offered at 11-14 weeks, to determine gestational age and detect multiple pregnancies. It may also be part of the screening for fetal anomalies when the nuchal translucency is measured. Accurate gestational age assessment helps optimal antenatal care by, for example, reducing the need for induction of labour at >41 weeks.
  • Crown-rump length is the best surrogate measure of gestational age in the first trimester.
  • Pregnant women who present at or beyond 14 weeks of gestation should be offered an ultrasound scan to estimate gestational age using head circumference or biparietal diameter. If the crown-rump length is above 84 mm, the gestational age should also be estimated using head circumference or biparietal diameter. By the second or third trimester, multiple parameters may be used, including biparietal diameter, head and abdominal circumference and femur length.

NEW - log your activity

  • Notes
    Add notes to any clinical page and create a reflective diary
  • Track
    Automatically track and log every page you have viewed
  • Print
    Print and export a summary to use in your appraisal
Click to find out more »
  • Nulliparous patients with uncomplicated pregnancies should be seen over a schedule of ten appointments.
  • Parous women with uncomplicated pregnancies should be seen over a schedule of seven appointments.

NICE recommends that the first antenatal appointment take place early in pregnancy (before 12 weeks) and that it may need to be booked as a double appointment due to the large amount of information and assessments that are required. Information must be imparted in a way the woman can understand and backed up with written information, so she is in a position to make informed choices regarding options and care in her pregnancy.

Information and advice which should be covered in the first appointment is detailed in the separate Antenatal Care article.

Examination routinely done at the first appointment includes:

  • Measurement of weight and height in order to determine body mass index (BMI).
  • Measurement of baseline blood pressure (BP).
  • Testing of urine for glycosuria/proteinuria.

Routine antenatal pelvic examination does not accurately assess gestational age, nor does it accurately predict preterm birth or cephalopelvic disproportion. It is not recommended.

Routine breast examination is not recommended.

The patient should be weighed at booking and her height measured so that her BMI can be calculated as weight in kilograms/(height in metres)2. This can be used as a baseline for future weighing where it is clinically indicated.

Routine weighing at antenatal appointments is no longer recommended unless there is a clinical indication.

  • Test for asymptomatic bacteriuria early in pregnancy using dipstick testing; send midstream specimen of urine (MSU) if indirect test is positive.
  • Test for proteinuria at each antenatal appointment (along with BP as part of regular surveillance for pre-eclampsia).
  • Check for glycosuria at every visit; if there is glycosuria of more than 2+ on one occasion, or 1+ on two or more occasions, test further to exclude gestational diabetes. An oral two-hour glucose tolerance test is normally used. See the separate Glucose Tolerance Tests and Gestational Diabetes articles.
  • Measure BP at presentation and at every subsequent appointment.
  • More frequent BP measurements should be performed in women with any risk factors for pre-eclampsia (determined at booking):
    • Age >40.
    • Nulliparous
    • Family history.
    • Previous history of pre-eclampsia.
    • BMI ≥35 at presentation.
    • Multiple pregnancy.
    • Pregnancy interval of more than 10 years.
    • Vascular disease - eg, hypertension.
    • Renal disease.
    • Diabetes.

Schedule further appointments accordingly to allow appropriate monitoring of BP. Where it is raised, NICE advises that:

  • A single diastolic blood pressure of 110 mm Hg or two consecutive readings of 90 mm Hg at least four hours apart and/or significant proteinuria (1+) should prompt increased surveillance.
  • If the systolic blood pressure is above 160 mm Hg on two consecutive readings at least four hours apart, treatment should be considered.
  • From 24 weeks, symphysis-fundal height should be measured and recorded at each appointment. If a fetus appears to be small or large for gestational age, this can be further assessed by ultrasound.
  • After 36 weeks, palpate the abdomen for possible malpresentation and confirm with an ultrasound scan if suspected.

NICE does NOT recommend:

  • Routine fetal auscultation by Pinard or Doppler in low-risk pregnancies, although this may be done if it is reassuring to women and requested. It is also required if there is clinical need, to help confirm the fetus is alive.
  • Routine fetal movement counting by pregnant women.

Offer an ultrasound examination:

  • Early in pregnancy (at 10-14 weeks) to:
    • Determine gestational age.
    • Detect multiple pregnancies.
    • Be part of the screening process for Down's syndrome and other chromosomal anomalies. (Nuchal translucency measured if screening desired.)
  • At 18-20 weeks, for congenital and structural anomalies - eg, cardiac, neural tube defects, renal abnormalities.
  • If the placenta is over the cervical os, offer a scan at 32 weeks, for placenta praevia.
  • If abnormalities are detected on clinical examination, such as malpresentation or being small or large for gestational age, or polyhydramnios is suspected.

The triennial confidential report of maternal and child health identifies many high-risk scenarios in pregnancy. Sepsis was identified as a preventable cause of death in pregnant women and the report emphasises the importance of routine measurements such as pulse, temperature, respiratory rate and blood pressure in any ill pregnant woman, and points out that pregnant women can become seriously ill very quickly.

Maternal deaths continue to gradually decline but it remains important to identify women at higher risk and pre-existing medical conditions and monitor/treat appropriately. Three quarters of the women who died in the years 2009-2012 informing the 2014 report had pre-existing medical or psychiatric conditions. Women with pre-existing medical morbidity should be seen in coordinated multidisciplinary medical and obstetric clinics. Although the following list is not exhaustive, these conditions can be associated with more adverse outcomes and warrant specialist opinion:

  • Cardiac disease, including hypertension.
  • Renal disease.
  • Diabetes treated with insulin, or any other endocrinological disorder.
  • Treated psychiatric disorder.
  • Haematological disease including propensity to thromboembolism and autoimmune disorder, such as antiphospholipid syndrome.
  • Epilepsy requiring anticonvulsant therapy.
  • Any current or recently treated malignant disease.
  • Significant respiratory impairment, including severe asthma.
  • Problematic alcohol use.
  • Regular/problematic use of recreational drugs such as heroin, cocaine, crack, ecstasy, etc.
  • Chronic viral infections - eg, HIV, hepatitis B virus (HBV), hepatitis C virus (HCV).
  • Autoimmune disorders.
  • Previous uterine surgery including caesarean section, myomectomy or cone biopsy.
  • BMI <18 or >30 kg/m2.
  • Women at higher risk of complications during pregnancy (eg, older than 40 years), smokers, very young mothers, and those without social support.
  • Problems associated with previous pregnancies:
    • Recurrent miscarriage (>3 consecutive pregnancy losses or a mid-trimester loss).
    • Preterm birth.
    • Severe pre-eclampsia, HELLP syndrome (Haemolysis, EL (elevated liver) enzymes, LP (low platelet) count), or eclampsia.
    • Rhesus isoimmunisation or other significant blood group autoantibodies.
    • Previous antepartum haemorrhage or postpartum haemorrhage on two occasions.
    • Retained placenta on two occasions.
    • Puerperal psychosis.
    • Grand multiparity (>6 children).
    • Previous stillbirth or neonatal death.
    • Small-for-gestational-age infant (<5th centile).
    • Large-for-gestational-age infant (>95th centile).
    • Baby weighing <2.5 kg or >4.5 kg.
    • Baby with a structural or chromosomal anomaly.

Further reading & references

  1. Antenatal care for uncomplicated pregnancies; NICE Clinical Guideline (March 2008)
  2. Butt K, Lim K; Determination of gestational age by ultrasound. J Obstet Gynaecol Can. 2014 Feb;36(2):171-83.
  3. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period; NICE Clinical Guideline (February 2015)
  4. Saving Lives, Improving Mothers’ Care - Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-2012; MBRRACE-UK, Dec 2014

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Sean Kavanagh
Current Version:
Peer Reviewer:
Dr John Cox
Document ID:
1808 (v28)
Last Checked:
01/12/2015
Next Review:
29/11/2020
Patient Access app - find out more Patient facebook page - Like our page